Aardvark Therapeutics
Nelson Sun is the Chief Financial Officer of Aardvark Therapeutics, Inc. Prior to joining Aardvark, Mr. Sun served as an Operating Partner at Dubilier & Company and as a Vice President at Valor Equity Partners. Mr. Sun holds an MBA in Finance from The Wharton School and an MA in International Studies from the School of Arts and Sciences at the University of Pennsylvania.
This person is not in any offices
Aardvark Therapeutics
Aardvark Therapeutics is a clinical stage biopharmaceutical company focused on developing novel small molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases, inflammation, and other indications.